Pharmaceuticals and Diagnostics
As an innovation-driven leader in healthcare, Roche aims to make a real difference in people's lives. We are pursuing this goal by providing products and services to prevent, diagnose, treat and monitor disease. Through our strong leadership in diagnostics and pharmaceuticals, Roche is in a unique position to innovate advances across a broad spectrum of healthcare. This combination of capabilities enables us to apply our breakthrough knowledge of diseases to develop innovative products that detect and monitor disease, and help guide choice in therapy. In turn, these aid in the discovery and development of innovative medicines offering hope of higher levels of efficacy and safety.
Personalised healthcare continues to be the guiding vision of our innovation strategy. Our Pharmaceuticals and Diagnostics organizations work together in increasingly integrated ways along the discovery-and-development-to-marketing continuum. Advanced science has helped us realize that a disease such as rheumatoid arthritis may not be a single condition, but rather a syndrome comprising many different diseases or conditions. By using diagnostic technologies in the early stages of pharmaceutical development, we hope to identify which particular sub-category of a disease is susceptible to a particular medicine. Diagnostic technologies also help us identify those patients who will benefit from a particular drug targeted to treat it. The result of this approach is a more clinically differentiated product - in other words, a medicine likely to be highly effective for a well-characterized disease condition in particular patient population.